The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...
NASHVILLE, Tenn. (WSMV) - A Nashville family bought a generator to heat their freezing home during the ice storm, only to be told by their homeowners association to remove it immediately or face fines ...
A Tennessee family was allegedly threatened with fines by their homeowners’ association to remove the generator that was heating their house, as the neighborhood was plunged into darkness during below ...
The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The union environment ministry has notified Solid Waste Management (SWM) Rules, 2026 for processing of waste by bulk waste generators under extended bulk waste generator responsibility (EBWGR), both ...
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. The Federal Trade Commission has agreed to what it ...
The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...
The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
Express Scripts to change practices tied to high costs FTC to enforce 10-year settlement Deal requires company to work with local pharmacies Sign up here. "Our ...
CEO Stephen Squeri emphasized the company’s ongoing momentum since its 2022 long-term growth aspirations, highlighting that “full year revenues were up 10% to a record $72 billion, and EPS was $15.38, ...
Cigna's top brass said that the company has anticipated a "clearing event" in the pharmacy benefit management industry, and that its new model aligns with regulators' push toward greater transparency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results